Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
USRE44599E1 · kind E1 · reissue
34Cited by
46References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 28, 2012 |
| Grant date | Nov 12, 2013 |
| Priority date | — |
| Expiry date | Dec 28, 2032 |
Classification
- Technology area (CPC —)General
Abstract
Compounds that inhibit P13Kδ activity, including compounds that selectively inhibit P13Kδ activity, are disclosed. Methods of inhibiting phosphatidylinositol 3-kinase delta isoform (P13Kδ) activity, and methods of treating diseases, such as disorders of immunity and inflammation in which P13Kδ plays a role in leukocyte function, using the compounds also are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.